InvestorsHub Logo
Followers 43
Posts 2425
Boards Moderated 0
Alias Born 02/09/2016

Re: ahab333 post# 23100

Saturday, 06/09/2018 12:06:43 PM

Saturday, June 09, 2018 12:06:43 PM

Post# of 233221
ahab333- As always from your posts, thank you!
Now from a blind squirrels see of things.
"Continuing access to PRO 140 is provided to patients completing 25 weeks in the trial."
wish they could pr their sentiments-
and
“With the highly favorable efficacy results for this combination therapy trial, and data from our previous trials and our ongoing monotherapy trial, we are now working toward the filing of a Biological License Application, or BLA, with the FDA for PRO 140 in the combination therapy indication,” added Dr. Pourhassan.

Since this data was embargoed prior to the meeting but on the agenda prior to the ASM, I would assume some time ago... BLA meeting or appt of meeting is near to a PR.
The elephants should be lining up at the door.
Chump

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News